Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury
Karin Nylén(Sahlgrenska University Hospital), Lars Rosengren(Sahlgrenska University Hospital), Bengt Nellgård(Sahlgrenska University Hospital), Martin Öst(Sahlgrenska University Hospital), L. Z. Csajbok(Sahlgrenska University Hospital), Christina Hall(Fujirebio (Belgium)), Inger Nilsson(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital)
Cited by 108
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
|The Lancet Neurology|2020|1.3k
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
|The Lancet Neurology|2017|630